1.
Musella A, Marchetti C, Gasparri ML, Salerno L, Casorelli A, Domenici L, Imperiale L, Ruscito I, Abdul Halim T, Palaia I, Di Donato V, Pecorini F, Monti M, Muzii L, Panici PB. PARP inhibition: A promising therapeutic target in ovarian cancer. Cell Mol Biol (Noisy-le-grand) [Internet]. 2015 Oct. 30 [cited 2024 Dec. 22];61(6):44-61. Available from: https://mail.cellmolbiol.org/index.php/CMB/article/view/723